Leerink Partners Downgrades Applied Therapeutics to Market Perform, Lowers Price Target to $1

Benzinga · 2d ago
Leerink Partners analyst Joseph Schwartz downgrades Applied Therapeutics (NASDAQ:APLT) from Outperform to Market Perform and lowers the price target from $2 to $1.